Notably, while NRF2 expression was enhanced at invasive tumor margins adjacent to normal kidney, compared to central areas of tumors, this was not observed in MS‐275‐treated tumors (Fig EV5B). The gene discussed is NFE2L2; the disease is neoplasm.